A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia
Clinical trial NCT05870917 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05870917
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2026-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.